Literature DB >> 15608688

Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene.

Weng-Onn Lui1, Theodoros Foukakis, Johan Lidén, Srinivasan R Thoppe, Trisha Dwight, Anders Höög, Jan Zedenius, Göran Wallin, Mark Reimers, Catharina Larsson.   

Abstract

The demonstration of the PAX8-PPAR(gamma) fusion oncogene in a subset of follicular thyroid tumors provides a new and promising starting point to dissect the molecular genetic events involved in the development of this tumor form. In the present study, we compared the gene expression profiles of follicular thyroid carcinomas (FTCs) bearing a PAX8-PPAR(gamma) fusion against FTCs that lack this fusion. Using unsupervised clustering and multidimensional scaling analyses, we show that FTCs possessing a PAX8-PPAR(gamma) fusion have a highly uniform and distinct gene expression signature that clearly distinguishes them from FTCs without the fusion. The PAX8-PPAR(gamma)(+) FTCs grouped in a defined cluster, where highly ranked genes were mostly associated with signal transduction, cell growth and translation control. Notably, a large number of ribosomal protein and translation-associated genes were concurrently underexpressed in the FTCs with the fusion. Taken together, our findings further support that follicular carcinomas with a PAX8-PPAR(gamma) rearrangement constitute a distinct biological entity. The current data represent one step to elucidate the molecular pathways in the development of FTCs with the specific PAX8-PPAR(gamma) fusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15608688     DOI: 10.1038/sj.onc.1208135

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  20 in total

1.  Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.

Authors:  Ludovic Lacroix; Vladimir Lazar; Stefan Michiels; Hugues Ripoche; Philippe Dessen; Monique Talbot; Bernard Caillou; Jean-Pierre Levillain; Martin Schlumberger; Jean-Michel Bidart
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

Review 2.  Understanding the genotype of follicular thyroid tumors.

Authors:  Jennifer Hunt
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 3.  Pax-8-PPAR-γ fusion protein in thyroid carcinoma.

Authors:  Priyadarshini Raman; Ronald J Koenig
Journal:  Nat Rev Endocrinol       Date:  2014-07-29       Impact factor: 43.330

4.  Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.

Authors:  Luke K Genutis; Jerneja Tomsic; Ralf A Bundschuh; Pamela L Brock; Michelle D Williams; Sameek Roychowdhury; Julie W Reeser; Wendy L Frankel; Mohammed Alsomali; Mark J Routbort; Russell R Broaddus; Paul E Wakely; John E Phay; Christopher J Walker; Albert de la Chapelle
Journal:  Thyroid       Date:  2019-03-27       Impact factor: 6.568

Review 5.  Translocations in epithelial cancers.

Authors:  J Chad Brenner; Arul M Chinnaiyan
Journal:  Biochim Biophys Acta       Date:  2009-05-04

6.  Molecular detection of PPAR gamma rearrangements and thyroid carcinoma in preoperative fine-needle aspiration biopsies.

Authors:  Christopher A French; Jonathan A Fletcher; Edmund S Cibas; Christopher Caulfield; Paulette Allard; Todd G Kroll
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

7.  PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.

Authors:  Rajani Kanteti; Vidya Nallasura; Sivakumar Loganathan; Maria Tretiakova; Todd Kroll; Soundararajan Krishnaswamy; Leonardo Faoro; Philip Cagle; Aliya N Husain; Everett E Vokes; Deborah Lang; Ravi Salgia
Journal:  Lab Invest       Date:  2009-01-12       Impact factor: 5.662

Review 8.  New agents in the treatment for malignancies of the salivary and thyroid glands.

Authors:  Ranee Mehra; Roger B Cohen
Journal:  Hematol Oncol Clin North Am       Date:  2008-12       Impact factor: 3.722

Review 9.  Role of surgeons in clinical trials for thyroid cancer.

Authors:  Y Nancy You; Samuel A Wells
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 10.  Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors.

Authors:  Changxue Lu; Sheue-Yann Cheng
Journal:  J Mol Endocrinol       Date:  2009-09-09       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.